THOMPSON SIEGEL & WALMSLEY LLC – Regeneron Pharmaceuticals, Inc. Transaction History
THOMPSON SIEGEL & WALMSLEY LLC portfolio value:
$7.85M
portfolio value
THOMPSON SIEGEL & WALMSLEY LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -0.83% | -96 shares | 1.05M | $688.87 | 11.40K |
| Q2 2022 | share | Increase | +0.31% | 35 shares | -1.20M | $591.13 | 11.49K |
| Q1 2022 | share | Increase | +0.62% | 71 shares | 812K | $698.42 | 11.46K |
| Q4 2021 | share | Increase | +2.82% | 313 shares | 490K | $642.51 | 11.39K |
| Q3 2021 | share | Increase | +2.17% | 235 shares | 648K | $605.18 | 11.08K |
| Q2 2021 | share | Increase | 0.00% | 10.84K shares | 6.05M | $558.54 | 10.84K |
| Q2 2018 | share | Decrease | -100.00% | -41 shares | -14K | $344.99 | 0 |
| Q1 2018 | share | 0.00% | 0 shares | -1K | $344.36 | 41 | |
| Q4 2017 | share | 0.00% | 0 shares | -3K | $375.96 | 41 | |
| Q3 2017 | share | 0.00% | 0 shares | -2K | $447.12 | 41 | |
| Q2 2017 | share | 0.00% | 0 shares | 4K | $491.14 | 41 | |
| Q1 2017 | share | Decrease | -12.77% | -6 shares | -1K | $387.51 | 41 |
| Q4 2016 | share | 0.00% | 0 shares | -2K | $367.09 | 47 | |
| Q3 2016 | share | 0.00% | 0 shares | 3K | $402.02 | 47 | |
| Q2 2016 | share | Increase | 0.00% | 47 shares | 16K | $349.23 | 47 |